Download - Class antiparkinsonian drugs
![Page 1: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/1.jpg)
Dr. RAGHU PRASADA M SMBBS,MDASSISTANT PROFESSORDEPT. OF PHARMACOLOGYSSIMS & RC.
1
![Page 2: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/2.jpg)
It is a chronic, progressive, motor disordercharacterized by
Tremor, resting Rigidity, cogwheel Akinesia, bradykinesia Postural InstabilityETIOLOGY-genetic, environmental toxins, andendogenous toxins, from cellular oxidative reactions.Two major pathogenetic hypotheses:Misfolding of proteinsMitochondrial dysfunction and oxidative stress
Pope John PaulII
![Page 3: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/3.jpg)
Behavioral – depression, anxiety, decreasedmotivation, personality changes,
Sensory – non-specific pains,, restless legs and othersleep problems
Autonomic – constipation, bladder dysfunction,impotence, low blood pressure
MuhammadAli
![Page 4: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/4.jpg)
DRUGS THAT INCREASE DOPAMINE LEVELSDA PRECURSOR-LEVODOPADRUGS THAT RELEASE DOPAMINE-AMANTIDINEDOPAMINERGIC AGONISTS-BROMOCRIPTINEPERGOLIDE, LISURIDE, ROPINIROLE
INHIBIT DOPAMINE METABOLISM-MAO INHIBITORS-SELEGILINE, RASGILINECOMT INHIBITORS-TOLCAPONE, ENTACAPONE
![Page 5: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/5.jpg)
DRUGS INFLUENCING CHOLINERGIC SYSTEM CENTRAL ANTICHLINERGICS-BENZTROPINE,
BENZHEXOL, BIPERIDINE ANTIHISTAMINES-DIPHENHYDRAMINE,
ORPHENADRINE, PROMETHAZINE
![Page 6: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/6.jpg)
Bradykinesia, rigidity, mild tremor, rabbit syndromeCaused by exposure to a dopamine-receptorblocking agent within 6 months of the onset ofsymptoms
Offending drugs include: antipsychotics, anti-emetics,metoclopramide1. Mild cases can frequently remit after cessation of the
offending drug2. Usually unresponsive to dopaminergic therapy3. Elderly patients are most susceptible4. Treatment may include: tetrabenazine, reserpine,
vitamin E, benzodiazepines
![Page 7: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/7.jpg)
![Page 8: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/8.jpg)
still the best, especially short term long term use – motor fluctuations, dyskinesias inversely proportional to age but – nearly all patients eventually require it extends half-life of levodopa, early use for early symptomatic treatment and for rapid
response, i.e. to aid patient to continue working –especially for rigidity & bradykinesia
![Page 9: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/9.jpg)
Helps bradykinesia and rigidity (not really tremor) Small dose increments every few days 6-18 months to see improvementADR- Nausea/flushing/sweating/neuropathyDEMERITS-On-off effect
End of dose deterioration
![Page 10: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/10.jpg)
Ropinorole, Pramipexole, Pergolide Bromocriptine/Cabergoline now avoided due to
cardiac valvulopathy and pleural, pericardial andretroperitoneal fibrosis
Dose -incremental increases Similar S/E profile, less motor complications but less
improvement
![Page 11: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/11.jpg)
DEMERITS-impulse control disorders and excessivedaytime somnolence Hypotension particularly in first few days of
treatment Good evidence in advanced PD to improve off time-
transdermal Rotigotine Amantadine-weak dopamine agonist Increasing Dopamine Agonists often worsens
hallucinations
![Page 12: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/12.jpg)
Antiviral properties. Weak DA, NMDA-receptor antagonist properties-
interferes with excessive glutamate, Glutamateantagonist.
Only for moderate to severe dyskinesia. 100 mg. BD or TDS for dyskinesias -SE-livedo reticularis, ankle edema, hallucinations
![Page 13: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/13.jpg)
Similar to levodopa Nausea. Vomiting. Postural hypotension. Confusion. Hallucinations. Somnolence.
![Page 14: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/14.jpg)
Delays or reduces breakdown of dopamine by MAO-B.Used as monotherapy or in conjunction with L-DOPA, itcan reduce the dosage of L-DOPA by 15%.
MAO-B is an enzyme that metabolizes dopamine.From the breakdown of dopamine, hydrogen peroxide isproduced, which the oxidative stress can damagedopaminergic neurons in the substantia nigra. (Possiblyneuroprotective)Side effects of L-DOPA may be enhanced by selegeline. Nausea and dizziness.
14
![Page 15: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/15.jpg)
Inactivates and degrades neurotransmitters,such as dopamine. Mainly used in combination with L-DOPA, it
increases the half-life of L-DOPA. Delays “wearing-off” effect of L-DOPA and
other motor complications such as dyskinesia
15
![Page 16: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/16.jpg)
COMT catalyzes methylation of L-DOPA. Addition of COMT inhibitor along with L-DOPA
and carbidopa prolongs the half-life of L-DOPAand increases the amount in the CNS.This increases “on” time for L-DOPA.
Diarrhea and sleep disturbances
16
![Page 17: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/17.jpg)
Before commerciality of levodopa, surgicaltreatment were preferred.
Early surgeries were successful with tremors, butfailed to relieve other symptoms.
“Means of last resort” due to high risk of potentialcomplications.
Recent advances in neurosurgical procedures allowfor better treatment.
Deep Brain Stimulation-Brain pacemaker, sendselectrical impulses to brain to stimulate thesubthalamic nucleus.
17
![Page 18: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/18.jpg)
MAO-B inhibitors Buccal selegiline or rasagiline can help motor
complications (less commonly used) Severe PD-can admit for subcutaneous
Apomorphine infusion New treatments-dopamine pump if others fail
![Page 19: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/19.jpg)
- Benzatropine, Procyclidine, Orphenadrine- Limited use.- Cognitive impairment in elderly.- Useful in drug induced Parkinsonism.- can be used for excessive salivation.
![Page 20: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/20.jpg)
Orphenadrine-helps drooling Often drooling is more unpleasant for family & they
are delighted if you can improve this Procyclidine-Best in drug-induced Parkinsonism s/e
control SE-confusion, hallucinations, dry mouth, blurred
vision, constipation, nausea, u. retention, glaucoma
![Page 21: Class antiparkinsonian drugs](https://reader031.vdocument.in/reader031/viewer/2022020123/55a602ad1a28abc4498b480c/html5/thumbnails/21.jpg)